Type to search

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent | Pharmtech Focus
Swissmedic Authorizes Moderna’s Omicron-targeting Bivalent Booster Candidate, mRNA-1273.214 | Pharmtech Focus
£10.4m Full-service Contract Signed With Existing Big Pharma Client | Pharmtech Focus